---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-007610"
form_type: "8-K"
ticker: "IMNM"
cik: "0001472012"
company_name: "Immunome Inc."
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T05:14:56.930850+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Immunome prices upsized $150M public offering of common stock at $7.75/share

## Summary
- 19,354,839 shares priced at $7.75 per share; gross proceeds $150M.
- Underwriters granted 30-day option to buy up to 2,903,225 additional shares.
- Offering expected to close Jan 31, 2025, subject to customary closing conditions.
- Joint book-running managers: J.P. Morgan, TD Cowen, Leerink Partners, Guggenheim Securities.
- Offering upsized from initially announced $125M; all shares sold by Immunome.

## SEC filing metadata
- accession: 0001104659-25-007610
- form_type: 8-K
- ticker: IMNM
- cik: 0001472012
- company_name: Immunome Inc.
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472012/000110465925007610/0001104659-25-007610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472012/000110465925007610/tm254657d4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-007610
- JSON: https://secwatch.observer/filing/0001104659-25-007610.json
- Plain text: https://secwatch.observer/filing/0001104659-25-007610.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.